8x8 Inc
SWB:EGT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
8
|
8x8 Inc
SWB:EGT
|
US |
|
K
|
Kalbe Farma Tbk PT
XBER:LCLA
|
ID |
|
Do & Co AG
F:DOQ
|
AT |
|
S
|
SPX Corp
XBER:SPW
|
US |
|
V
|
Vifor Pharma AG
LSE:0RPD
|
CH |
|
S
|
Shandong Weigao Group Medical Polymer Co Ltd
SWB:UK2
|
CN |
|
M
|
Mandalay Resources Corp
OTC:MNDJF
|
CA |
Wall St Price Targets
EGT Price Targets Summary
8x8 Inc
According to Wall Street analysts, the average 1-year price target for EGT is 2.19 EUR with a low forecast of 1.31 EUR and a high forecast of 2.73 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is EGT's stock price target?
Price Target
2.19
EUR
According to Wall Street analysts, the average 1-year price target for EGT is 2.19 EUR with a low forecast of 1.31 EUR and a high forecast of 2.73 EUR.
What is the Revenue forecast for 8x8 Inc?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Revenue has been 18%. The projected CAGR for the next 3 years is 3%.
What is the Operating Income forecast for 8x8 Inc?
Projected CAGR
1%
Over the last 13 years, the compound annual growth rate for Operating Income has been 4%. The projected CAGR for the next 3 years is 1%.
